Vinpocetine is the forthcoming adjuvant agent in the management of COVID-19

Vinpocetine is the forthcoming adjuvant agent in the management of COVID-19

Vinpocetine (VPN) is an alkaloid derivative of vincamine inhibits phosphodiesterase type 1 that increase cyclic guanosine monophosphate and cyclic adenosine monophosphate. VPN have anti-inflammatory and antioxidant effects with suppression release of pro-inflammatory cytokines. Moreover, VPN mitigat...

Full description

Bibliographic Details
Main Authors: Hayder M Al-kuraishy, Ali I Al-Gareeb, Muyiwa Samuel Fageyinbo, Gaber El-Saber Batiha
Format: Article
Language:English
Published: Taylor & Francis Group 2022-06-01
Series:Future Science OA
Subjects:
anti-inflammatory
anti-oxidant effects
COVID-19
hyper-inflammation
oxidative stress
phosphodiesterase inhibitor
Online Access:https://www.future-science.com/doi/10.2144/fsoa-2021-0099

Internet

https://www.future-science.com/doi/10.2144/fsoa-2021-0099

Similar Items